Prof. Dr. Rembert Koczulla
Chefarzt - Fachzentrum für Pneumologie
Internist, Pneumologe, Intensivmediziner, Notfallmediziner, Physikalische Therapie, Balneologie
Lebenslauf
Engagement
Mitgliedschaft
- Deutsche Gesellschaft für Innere Medizin (DGIM)
- Deutsche Gesellschaft für Pneumologie (DGP)
- Europäische Gesellschaft für Pneumologie
- Ehrenmitglied der Rumänischen Gesellschaft für Pneumologie
Wissenschaftlicher Preis
- 2022 - Hessischer Sportarzt des Jahres
Sonstiges
-
2025 -
Beraterfunktion für die WHO und OECD
-
2021 -
Beraterfunktion für die Bundesregierung (Deutschland)
Publikationen
Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Ersöz H, Torres-Durán M, Turner AM, Tanash H, Rodríguez García C, Corsico AG, López-Campos JL, Miravitlles M, Clarenbach CF, Chapman KR, Hernández Pérez JM, Guimarães C, Bartošovská E, Greul Arch Bronconeumol. 2025 Jan;61(1):22-30. doi: 10.1016/j.arbres.2024.06.019. Epub 2024 Jul 9.PMID: 39068055 Free article. English, Spanish. (IF:1.79)
A High-Intensity versus Moderate-Intensity Exercise Training Programme in Alpha-1 Antitrypsin Deficiency-Related COPD (IMAC): A Randomized, Controlled Trial
Jarosch I, Schneeberger T, Gloeckl R, Kroll D, Dennis C, Hitzl W, Kenn K, Koczulla AR. Respiration. 2025;104(3):200-205. doi: 10.1159/000541448. Epub 2024 Oct 19.PMID: 39427652 Clinical Trial. (IF:3.5)
Diffusion capacity and static hyperinflation as markers of disease progression predict 3-year mortality in COPD: Results from COSYCONET
Pott H, Weckler B, Gaffron S, Martin R, Maier D, Alter P, Biertz F, Speicher T, Bertrams W, Jung AL, Laakmann K, Heider D, Wouters M, Vogelmeier CF, Schmeck B; COSYCONET Study Group. Respirology. 2025 Feb;30(2):134-146. doi: 10.1111/resp.14843. Epub 2024 Oct 24.PMID: 39448064 Free PMC article.(IF:6.6)
Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial
Gloeckl R, Spielmanns M, Stankeviciene A, Plidschun A, Kroll D, Jarosch I, Schneeberger T, Ulm B, Vogelmeier CF, Koczulla AR. Thorax. 2025 Mar 18;80(4):209-217. doi: 10.1136/thorax-2024-221803.PMID: 39706685 Free article. Clinical Trial. (IF:9.2)
Costs and Complications of Respiratory Syncytial Virus and Acute Respiratory Infections in the Adult Population: Analysis of a German Claims Database
Marijic P, Kliemt R, Krammer M, Kolb N, Last T, Ambrosch A, Ewig S, Koczulla R, Schelling J, Vogelmeier C, Waize M, Stierl M, Fonseca MJ, Pedron S, Marijam A. Pharmacoecon Open. 2025 Mar 19. doi: 10.1007/s41669-025-00565-3. Online ahead of print.PMID: 40108096 Free article. (IF:1.94)
Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial
Jarosch I, Schneeberger T, Stegemann A, Gloeckl R, Leitl D, Dennis C, Hitzl W, Schoen C, Koczulla AR.Jarosch I, et al. Respiration. 2024;103(4):177-181. doi: 10.1159/000536272. Epub 2024 Mar 1.Respiration. 2024. PMID: 38432219 (IF:3.5)
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET
Fähndrich S, Herr C, Teuteberg S, Alter P, Söhler S, Soriano D, Classen J, Adams J, Weinhold V, Watz H, Waschki B, Zeller T, Eichenlaub M, Trudzinski FC, Michels JD, Omlor A, Seiler F, Monek German COSYCONET Cohort.Respir Res. 2024 Jan 24;25(1):56. doi: 10.1186/s12931-024-02690-9.PMID: 38267944 (IF:5.8)
Practical Recommendations for Exercise Training in Patients with Long COVID with or without Post-exertional Malaise: A Best Practice Proposal
Gloeckl R, Zwick RH, Fürlinger U, Schneeberger T, Leitl D, Jarosch I, Behrends U, Scheibenbogen C, Koczulla AR.Gloeckl R, et al. Sports Med Open. 2024 Apr 24;10(1):47. doi: 10.1186/s40798-024-00695-8.Sports Med Open. 2024. PMID: 38658496 (IF:5.7)
COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases
Reemann L, Kneidinger N, Sczepanski B, Koczulla R, Reemann L, et al. Viruses. 2024 Apr 29;16(5):709. doi: 10.3390/v16050709.Viruses. 2024. PMID: 38793590 (IF:3.8)
Specific molecular peak analysis by ion mobility spectrometry of volatile organic compounds in urine of COVID-19 patients: A novel diagnostic approach
Boeselt T, Terhorst P, Kroenig J, Nell C, Spielmanns M, Boas U, Veith M, Vogelmeier C, Greulich T, Koczulla AR, Beutel B, Huber J, Heers H.Boeselt T, et al. J Virol Methods. 2024 May;326:114910. doi: 10.1016/j.jviromet.2024.114910. Epub 2024 Mar 5.J Virol Methods. 2024. PMID: 38452823 (IF:2.2)
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort
Frantzi N, Nguyen XP, Herr C, Alter P, Söhler S, Soriano D, Watz H, Waschki B, Trinkmann F, Eichenlaub M, Trudzinski FC, Michels-Zetsche JD, Omlor A, Seiler F, Moneke I, Biertz F, Rohde G, S Respir Res. 2024 May 15;25(1):207. doi: 10.1186/s12931-024-02822-1.Respir Res. 2024. PMID: 38750572 (IF:5.8)
Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach
Heers H, Gut JM, Hofmann R, Flegar L, Derigs M, Huber J, Baumbach JI, Koczulla AR, Boeselt T.Heers H, et al. World J Urol. 2024 May 25;42(1):353. doi: 10.1007/s00345-024-05047-5.World J Urol. 2024. PMID: 38795133 (IF: 2.8)
Updated S1 guideline on long/post-COVID: relevant aspects for pain medicine
Lemhöfer C, Koczulla AR, Meissner W, Häuser W.Lemhöfer C, et al. Schmerz. 2024 Jun;38(3):175-182. doi: 10.1007/s00482-023-00704-x. Epub 2023 Mar 16.Schmerz. 2024. PMID: 36929455 (IF:1.1)
VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach
Heers H, Chwilka O, Huber J, Vogelmeier C, Koczulla AR, Baumbach JI, Boeselt T.Heers H, et al. Prostate. 2024 Jun;84(8):756-762. doi: 10.1002/pros.24692. Epub 2024 Mar 18.Prostate. 2024. PMID: 38497426 (IF:2.6)
S1 guideline long/post-COVID syndrome
Gogoll C, Peters E, Köllner V, Koczulla R. Urologie. 2024 Jun 17. doi: 10.1007/s00120-024-02373-9. Online ahead of print.Urologie. 2024. PMID: 38886205 German. (IF:1.2)
Outpatient exercise training for chronic lung disease - for whom, how and why?
Gloeckl R, Jarosch I, Koczulla R Dtsch Med Wochenschr. 2024 Nov;149(22):1367-1371. doi: 10.1055/a-2165-5788. Epub 2024 Oct 22.PMID: 39437830 German. (IF:0.65)
Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)
Ringshausen FC, Baumann I, de Roux A, Dettmer S, Diel R, Eichinger M, Ewig S, Flick H, Hanitsch L, Hillmann T, Koczulla R, Köhler M, Koitschev A, Kugler C, Nüßlein T, Ott SR, Pink I, Pletz M Pneumologie. 2024 Nov;78(11):833-899. doi: 10.1055/a-2311-9450. Epub 2024 Nov 8.PMID: 39515342 German (IF:0.29)
Rehabilitative interventions in patients with persistent post COVID-19 symptoms-a review of recent advances and future perspectives
Gloeckl R, Leitl D, Schneeberger T, Jarosch I, Koczulla AR. Eur Arch Psychiatry Clin Neurosci. 2024 Dec;274(8):1819-1828. doi: 10.1007/s00406-023-01631-9. Epub 2023 Jun 16.PMID: 37326700 Free PMC article. Review. (IF:5.8)
Diagnosis and treatment of asthma: a guideline for respiratory specialists
Lommatzsch M, Criée CP, de Jong CCM, Gappa M, Geßner C, Gerstlauer M, Hämäläinen N, Haidl P, Hamelmann E, Horak F, Idzko M, Ignatov A, Koczulla AR, Korn S, Köhler M, Lex C, et al. Pneumologie. 2023 Aug;77(8):461-543. doi: 10.1055/a-2070-2135. Epub 2023 Jul 5.PMID: 37406667 Free article. German. (IF: 1,2)
S2k-Guideline SARS-CoV-2, COVID-19 and (early) rehabilitation - a consensus-based guideline for Germany
Platz T, Berlit P, Dohle C, Fickenscher H, Guha M, Köllner V, Kramer A, Koczulla R, Schlitt GMS Hyg Infect Control. 2023 May 12;18:Doc12. doi: 10.3205/dgkh000438. eCollection 2023.PMID: 37261059 Free PMC article. (IF: 0,38)
The problem of long/post-COVID in expert assessments
Eyfferth T, Koczulla AR, Freytag HW, Krahl G, Ackermann C, Bultmann S, Reimertz R, Dresing K Sektion Begutachtung der DGOU.Unfallchirurgie (Heidelb). 2023 May;126(5):373-386. doi: 10.1007/s00113-023-01297-x. Epub 2023 Apr 20.PMID: 37079057 Free PMC article. Review. German. (IF: 0,8)
S1 guidelines for the management of postviral conditions using the example of post-COVID-19
Rabady S, Hoffmann K, Aigner M, Altenberger J, Brose M, Costa U, Denk-Linnert DM, Gruber S, Götzinger F, Helbok R, Hüfner K, Koczulla R, Kurz K, Lamprecht B, Leis S, Löffler J, Müller CA, Ri Wien Klin Wochenschr. 2023 Jul;135(Suppl 4):525-598. doi: 10.1007/s00508-023-02242-z. Epub 2023 Aug 9.PMID: 37555900 Free PMC article. German. (IF: 2,4)